Merge branch 'zhangyuanshan' into dev

env/.env.prod

@@ -7,4 +7,4 @@ VITE_SHOW_SOURCEMAP = false
 VITE_BASEURL = '//appointteam.szjixun.cn'
 
 # 文档查看
-VITE_PAGE_URL="https://www.fiee.com"
+VITE_PAGE_URL="http://172.16.100.22:8045"

googledeec2461668656b4.html

@@ -1 +0,0 @@
-google-site-verification: googledeec2461668656b4.html

src/views/boarddirectors/size1440/index.vue

@@ -38,12 +38,12 @@ const otherDirectors = [
     contain:
       "Previously served as the treasury director of Taifeng Cultural Communication Co., Ltd where she oversees its financial matters from November 2018 to November 2024. Prior to that, Ms. Cao served as a business manager of Yangfeng Art Exchange Co., Ltd from February 2016 to October 2018. From March 2011 to January 2016, she served as the treasury officer of financial department of Suzhou Industrial Park Xinfushida Plastic Profile Products Co., Ltd.",
   },
-  // {
+  {
-  //   name: "David E. Lazar",
+    name: "David E. Lazar",
-  //   title: "Director",
+    title: "Director",
-  //   contain:
+    contain:
-  //     "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
+      "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
-  // },
+  },
 
   {
     name: "David Natan",

src/views/boarddirectors/size1920/index.vue

@@ -34,12 +34,12 @@ const otherDirectors = [
     contain:
       "Previously served as the treasury director of Taifeng Cultural Communication Co., Ltd where she oversees its financial matters from November 2018 to November 2024. Prior to that, Ms. Cao served as a business manager of Yangfeng Art Exchange Co., Ltd from February 2016 to October 2018. From March 2011 to January 2016, she served as the treasury officer of financial department of Suzhou Industrial Park Xinfushida Plastic Profile Products Co., Ltd.",
   },
-  // {
+  {
-  //   name: "David E. Lazar",
+    name: "David E. Lazar",
-  //   title: "Director",
+    title: "Director",
-  //   contain:
+    contain:
-  //     "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
+      "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
-  // },
+  },
 
   {
     name: "David Natan",

src/views/boarddirectors/size375/index.vue

@@ -34,12 +34,12 @@ const otherDirectors = [
     contain:
       "Previously served as the treasury director of Taifeng Cultural Communication Co., Ltd where she oversees its financial matters from November 2018 to November 2024. Prior to that, Ms. Cao served as a business manager of Yangfeng Art Exchange Co., Ltd from February 2016 to October 2018. From March 2011 to January 2016, she served as the treasury officer of financial department of Suzhou Industrial Park Xinfushida Plastic Profile Products Co., Ltd.",
   },
-  // {
+  {
-  //   name: "David E. Lazar",
+    name: "David E. Lazar",
-  //   title: "Director",
+    title: "Director",
-  //   contain:
+    contain:
-  //     "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
+      "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
-  // },
+  },
 
   {
     name: "David Natan",

src/views/boarddirectors/size768/index.vue

@@ -38,12 +38,12 @@ const otherDirectors = [
     contain:
       "Previously served as the treasury director of Taifeng Cultural Communication Co., Ltd where she oversees its financial matters from November 2018 to November 2024. Prior to that, Ms. Cao served as a business manager of Yangfeng Art Exchange Co., Ltd from February 2016 to October 2018. From March 2011 to January 2016, she served as the treasury officer of financial department of Suzhou Industrial Park Xinfushida Plastic Profile Products Co., Ltd.",
   },
-  // {
+  {
-  //   name: "David E. Lazar",
+    name: "David E. Lazar",
-  //   title: "Director",
+    title: "Director",
-  //   contain:
+    contain:
-  //     "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
+      "Served as the Chief Executive Officer of OpGen, Inc., a precision medicine company listed on the Nasdaq (OPGN) since April 11, 2024, where he also servs as a director and board chairman, beginning on March 25, 2024. Mr. Lazar served as the Chief Executive Officer of Titan Pharmaceuticals Inc. listed on the Nasdaq (TTNP) from August 2022 through April 11, 2024, where he also served as a director and board chairman from August 2022 until October 2023. He has also served as the CEO of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018. In his role as Chief Executive Officer of Custodian Ventures LLC, Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries.",
-  // },
+  },
 
   {
     name: "David Natan",

src/views/financialinformation/secfilings/size1440/index.vue

@@ -194,7 +194,7 @@ onMounted(() => {
 import axios from "axios";
 const getListData = async () => {
   state.tableData = [];
-  let url = "https://erpapi.fiee.com/api/fiee/sec-filing/web/list";
+  let url = "http://common.szjixun.cn//api/fiee/sec-filing/web/list";
   let params = {
     page: state.currentPage,
     pageSize: state.pageSize,

src/views/financialinformation/secfilings/size1920/index.vue

@@ -195,7 +195,7 @@ onMounted(() => {
 import axios from "axios";
 const getListData = async () => {
   state.tableData = [];
-  let url = "https://erpapi.fiee.com/api/fiee/sec-filing/web/list";
+  let url = "http://common.szjixun.cn//api/fiee/sec-filing/web/list";
   let params = {
     page: state.currentPage,
     pageSize: state.pageSize,

src/views/financialinformation/secfilings/size375/index.vue

@@ -195,7 +195,7 @@ onMounted(() => {
 import axios from "axios";
 const getListData = async () => {
   state.tableData = [];
-  let url = "https://erpapi.fiee.com/api/fiee/sec-filing/web/list";
+  let url = "http://common.szjixun.cn//api/fiee/sec-filing/web/list";
   let params = {
     page: state.currentPage,
     pageSize: state.pageSize,

src/views/financialinformation/secfilings/size768/index.vue

@@ -196,7 +196,7 @@ onMounted(() => {
 import axios from "axios";
 const getListData = async () => {
   state.tableData = [];
-  let url = "https://erpapi.fiee.com/api/fiee/sec-filing/web/list";
+  let url = "http://common.szjixun.cn//api/fiee/sec-filing/web/list";
   let params = {
     page: state.currentPage,
     pageSize: state.pageSize,

src/views/financialinformation/secfilingsdetail/size1440/index.vue

@@ -129,7 +129,7 @@ onMounted(() => {
 });
 import axios from "axios";
 const getPageData = async (filingKey) => {
-  let url = "https://erpapi.fiee.com/api/fiee/sec-filing/web/detail";
+  let url = "http://common.szjixun.cn//api/fiee/sec-filing/web/detail";
   let params = {
     filingKey,
   };

src/views/financialinformation/secfilingsdetail/size1920/index.vue

@@ -129,7 +129,7 @@ onMounted(() => {
 });
 import axios from "axios";
 const getPageData = async (filingKey) => {
-  let url = "https://erpapi.fiee.com/api/fiee/sec-filing/web/detail";
+  let url = "http://common.szjixun.cn//api/fiee/sec-filing/web/detail";
   let params = {
     filingKey,
   };

src/views/financialinformation/secfilingsdetail/size375/index.vue

@@ -129,7 +129,7 @@ onMounted(() => {
 });
 import axios from "axios";
 const getPageData = async (filingKey) => {
-  let url = "https://erpapi.fiee.com/api/fiee/sec-filing/web/detail";
+  let url = "http://common.szjixun.cn//api/fiee/sec-filing/web/detail";
   let params = {
     filingKey,
   };

src/views/financialinformation/secfilingsdetail/size768/index.vue

@@ -129,7 +129,7 @@ onMounted(() => {
 });
 import axios from "axios";
 const getPageData = async (filingKey) => {
-  let url = "https://erpapi.fiee.com/api/fiee/sec-filing/web/detail";
+  let url = "http://common.szjixun.cn//api/fiee/sec-filing/web/detail";
   let params = {
     filingKey,
   };

src/views/govern/size1440/index.vue

@@ -167,8 +167,8 @@ watch(() => state.list, () => {
 
 //获取官网展示文档
 const getGovernanceDisplay = () => {
-  // let url = 'https://erpapi.fiee.com/api/fiee/fiee/governance/display'
+  // let url = 'https://common.szjixun.cn/api/fiee/governance/display'
-  let url = 'https://erpapi.fiee.com/api/fiee/governance/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/governance/display'
   let params = {}
   axios
     .get(url, { params })

src/views/govern/size1920/index.vue

@@ -167,8 +167,8 @@ watch(() => state.list, () => {
 
 //获取官网展示文档
 const getGovernanceDisplay = () => {
-  // let url = 'https://erpapi.fiee.com/api/fiee/fiee/governance/display'
+  // let url = 'https://common.szjixun.cn/api/fiee/governance/display'
-  let url = 'https://erpapi.fiee.com/api/fiee/governance/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/governance/display'
   let params = {}
   axios
     .get(url, { params })

src/views/govern/size375/index.vue

@@ -163,8 +163,8 @@ watch(() => state.list, () => {
 
 //获取官网展示文档
 const getGovernanceDisplay = () => {
-  // let url = 'https://erpapi.fiee.com/api/fiee/fiee/governance/display'
+  // let url = 'https://common.szjixun.cn/api/fiee/governance/display'
-  let url = 'https://erpapi.fiee.com/api/fiee/governance/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/governance/display'
   let params = {}
   axios
     .get(url, { params })

src/views/govern/size768/index.vue

@@ -163,8 +163,8 @@ watch(() => state.list, () => {
 
 //获取官网展示文档
 const getGovernanceDisplay = () => {
-  // let url = 'https://erpapi.fiee.com/api/fiee/fiee/governance/display'
+  // let url = 'https://common.szjixun.cn/api/fiee/governance/display'
-  let url = 'https://erpapi.fiee.com/api/fiee/governance/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/governance/display'
   let params = {}
   axios
     .get(url, { params })

src/views/myHome/size1440/index.vue

@@ -258,7 +258,7 @@ const newList = ref([
 
 // 获取新闻发布(展示在首页的)
 const getPressReleasesDisplay = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases/display'
   let params = {
     page: 1,
     pageSize: 10,

src/views/myHome/size1920/index.vue

@@ -245,7 +245,7 @@ const newList = ref([
 
 // 获取新闻发布(展示在首页的)
 const getPressReleasesDisplay = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases/display'
   let params = {
     page: 1,
     pageSize: 10,

src/views/myHome/size375/index.vue

@@ -256,7 +256,7 @@ const newList = ref([
 
 // 获取新闻发布(展示在首页的)
 const getPressReleasesDisplay = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases/display'
   let params = {
     page: 1,
     pageSize: 10,

src/views/myHome/size768/index.vue

@@ -313,7 +313,7 @@ watch(() => newList.value, () => {
 
 // 获取新闻发布(展示在首页的)
 const getPressReleasesDisplay = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases/display'
   let params = {
     page: 1,
     pageSize: 10,

src/views/news/size1440/index.vue

@@ -26,7 +26,7 @@ onMounted(() => {
 
 //获取新闻信息
 const getPressReleasesInfo = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases?id=' + state.id
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases?id=' + state.id
   axios.get(url).then((res) => {
     // console.log(res)
     if (res.status === 200) {

src/views/news/size1920/index.vue

@@ -26,7 +26,7 @@ onMounted(() => {
 
 //获取新闻信息
 const getPressReleasesInfo = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases?id=' + state.id
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases?id=' + state.id
   axios.get(url).then((res) => {
     // console.log(res)
     if (res.status === 200) {

src/views/news/size375/index.vue

@@ -26,7 +26,7 @@ onMounted(() => {
 
 //获取新闻信息
 const getPressReleasesInfo = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases?id=' + state.id
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases?id=' + state.id
   axios.get(url).then((res) => {
     // console.log(res)
     if (res.status === 200) {

src/views/news/size768/index.vue

@@ -26,7 +26,7 @@ onMounted(() => {
 
 //获取新闻信息
 const getPressReleasesInfo = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases?id=' + state.id
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases?id=' + state.id
   axios.get(url).then((res) => {
     // console.log(res)
     if (res.status === 200) {

src/views/press-releases/size1440/index.vue

@@ -151,7 +151,7 @@ watch(() => state.filterNewsData, () => {
 
 // 获取新闻列表
 const getPressReleasesDisplay = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases/display'
   let params = {
     query: state.inputValue,
     page: state.currentPage,

src/views/press-releases/size1920/index.vue

@@ -151,7 +151,7 @@ watch(() => state.filterNewsData, () => {
 
 // 获取新闻列表
 const getPressReleasesDisplay = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases/display'
   let params = {
     query: state.inputValue,
     page: state.currentPage,

src/views/press-releases/size375/index.vue

@@ -158,7 +158,7 @@ watch(() => state.filterNewsData, () => {
 
 // 获取新闻列表
 const getPressReleasesDisplay = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases/display'
   let params = {
     query: state.inputValue,
     page: state.currentPage,

src/views/press-releases/size768/index.vue

@@ -151,7 +151,7 @@ watch(() => state.filterNewsData, () => {
 
 // 获取新闻列表
 const getPressReleasesDisplay = () => {
-  let url = 'https://erpapi.fiee.com/api/fiee/pressreleases/display'
+  let url = 'http://172.16.100.93:9020/api/fiee/pressreleases/display'
   let params = {
     query: state.inputValue,
     page: state.currentPage,